Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000240833

Medchemexpress LLC S-[2-[6-[[4-[3-(dimethylamino)propoxy]phenyl]sulfonylamino]-3-pyridinyl]-2-oxoethyl] ethanethioate | 940943-37-3 | MFCD19690928 | 98.1% | 451.56 g·mol⁻¹ | C20H25N3O5S2 | 25 MG
SDP

Catalog No. 5000240833
Encompass_Preferred

KD 5170 is a mercaptoketone-based pan inhibitor of histone deacetylases (HDACs) that demonstrates broad-spectrum antitumor activity in vitro and in vivo. It is supplied as a white to yellow solid for research use only.

  • Potent pan-histone deacetylase (HDAC) inhibition.
  • Demonstrated broad-spectrum antitumor activity in vitro and in vivo.
  • High reported purity (≈98.1%).
  • Available in small-mass pack sizes suitable for preclinical studies.
  • White to yellow solid form, convenient for storage and handling.
  • Intended for research use only and not for human therapeutic use.

Catalog No. 50-002-40833 Supplier Medchemexpress LLC Supplier No. HY10754925MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

KD 5170 is a mercaptoketone-based pan inhibitor of histone deacetylases (HDACs) that demonstrates broad-spectrum antitumor activity in vitro and in vivo. It is supplied as a white to yellow solid for research use only.

  • Potent pan-histone deacetylase (HDAC) inhibition.
  • Demonstrated broad-spectrum antitumor activity in vitro and in vivo.
  • High reported purity (≈98.1%).
  • Available in small-mass pack sizes suitable for preclinical studies.
  • White to yellow solid form, convenient for storage and handling.
  • Intended for research use only and not for human therapeutic use.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.